古屋秀和 (Hidekazu Furuya) - マイポータル

基本情報

所属: 昭和大学内科学講座リウマチ膠原病内科学部門

J-GLOBAL ID: 201801004862118654
researchmap会員ID: B000316111

論文

ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion.

Ishii S, Isozaki T, Furuya H, Takeuchi H, Tsubokura Y, Inagaki K, Kasama T

Arthritis research & therapy 20(1) 159 2018年8月査読有り
Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease (Clinical Rheumatology, (2018), 37, 4, (1017-1024), 10.1007/s10067-018-4014-5)

Airi Nishimi, Takeo Isozaki, Shinichiro Nishimi, Sho Ishii, Takahiro Tokunaga, Hidekazu Furuya, Kuninobu Wakabayashi, Tsuyoshi Kasama

Clinical Rheumatology 37(4) 1017-1024 2018年4月1日査読有り
ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease

Airi Nishimi, Takeo Isozaki, Shinichiro Nishimi, Sho Ishii, Takahiro Tokunaga, Hidekazu Furuya, Kuninobu Wakabayashi, Tsuyoshi Kasama

Clinical Rheumatology 37(4) 1025-1026 2018年4月1日査読有り
Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?

Yusuke Miwa, Hidekazu Furuya, Ryo Yanai, Tsuyoshi Kasama, Kenji Sanada

European journal of rheumatology 5(1) 22-26 2018年3月査読有り
Predictor of the simplified disease activity index 50 (SDAI 50) at month 3 of bDMARD treatment in patients with Long-Established rheumatoid arthritis

Yusuke Miwa, Mayu Saito, Hidekazu Furuya, Ryo Yanai, Tsuyoshi Kasama

Open Rheumatology Journal 11 106-112 2017年9月1日査読有り
Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment

Yusuke Miwa, Mayu Saito, Hidekazu Furuya, Ryo Yanai, Yuzo Ikari, Tomoki Hayashi, Tsuyoshi Kasama, Yoichi Toyoshima, Katsunori Inagaki

INTERNAL MEDICINE 56(17) 2271-2275 2017年査読有り
The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis

Yusuke Miwa, Hidekazu Furuya, Ryo Yanai, Tsuyoshi Kasama, Kenji Sanada

INTERNAL MEDICINE 56(23) 3167-3172 2017年査読有り
Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis

Ryo Takahashi, Sakiko Isojima, Masayu Umemura, Yoko Miura, Nao Oguro, Syo Ishii, Shinya Seki, Takahiro Tokunaga, Hiroyuki Tsukamoto, Hidekazu Furuya …

Open Access Rheumatology: Research and Reviews 6 57-64 2014年5月16日査読有り
Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis

Tsuyoshi Kasama, Sakiko Isojima, Masayu Umemura, Hiroyuki Tsukamoto, Takehiro Tokunaga, Hidekazu Furuya, Ryo Yanai, Ryo Takahashi, Masanori Nakamura, Katsunori Inagaki

RHEUMATOLOGY INTERNATIONAL 34(3) 429-433 2014年3月査読有り
Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis

Hidekazu Furuya, Tsuyoshi Kasama, Takeo Isozaki, Masayu Umemura, Kumiko Otsuka, Sakiko Isojima, Hiroyuki Tsukamoto, Takehiro Tokunaga, Ryo Yanai, Ryo Takahashi

Journal of Multidisciplinary Healthcare 6 25-30 2013年査読有り
Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome

Tsuyoshi Kasama, Hidekazu Furuya, Ryo Yanai, Kumiko Ohtsuka, Ryo Takahashi, Nobuyuki Yajima, Yusuke Miwa, Kazuo Kobayashi

CLINICAL RHEUMATOLOGY 31(5) 853-860 2012年5月査読有り